Recruiting Scleroderma Studies in Pittsburgh
About Scleroderma Clinical Trials in Pittsburgh
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 8 participants. Research is being sponsored by Paul Szabolcs. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Pittsburgh — FAQ
Are there scleroderma clinical trials in Pittsburgh?
Yes, there are 1 scleroderma clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Pittsburgh?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.
Are clinical trials in Pittsburgh free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov